NYSE:JNJPharmaceuticals
Can Johnson & Johnson (JNJ) Trade At A Discount Despite Talc Risk?
Johnson & Johnson stock has delivered a strong 77.8% total return over the past five years, yet the latest valuation checks send a mixed message, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to meaningful upside while the broader scorecard is less generous.
Over five years, Johnson & Johnson has returned 77.8%, which puts current buyers in the position of judging whether that run already reflects much of the good news.
Progress in higher value oncology...